The Alpha Thalassemia market is witnessing significant advancements due to enhanced diagnostic techniques and innovative therapies targeting gene mutations. Growing emphasis on personalized medicine and increasing adoption of novel therapeutics are driving substantial shifts in the industry, reflecting the evolving landscape of hematology and genetic disorder management.Market Size and Overview...